Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Capital Investment Advisors LLC

Capital Investment Advisors LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 778 shares of the medical equipment provider’s stock after buying an additional 53 shares during the quarter. Capital Investment Advisors LLC’s holdings in Intuitive Surgical were worth $382,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ISRG. Moss Adams Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 20.1% in the 3rd quarter. Moss Adams Wealth Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $308,000 after acquiring an additional 105 shares during the last quarter. KMG Fiduciary Partners LLC lifted its position in Intuitive Surgical by 1.0% during the third quarter. KMG Fiduciary Partners LLC now owns 14,228 shares of the medical equipment provider’s stock valued at $6,990,000 after purchasing an additional 140 shares during the period. Net Worth Advisory Group purchased a new stake in Intuitive Surgical in the third quarter valued at $800,000. Stratos Wealth Advisors LLC grew its position in Intuitive Surgical by 2.7% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 6,095 shares of the medical equipment provider’s stock worth $2,994,000 after purchasing an additional 162 shares during the period. Finally, Stratos Wealth Partners LTD. grew its position in Intuitive Surgical by 5.8% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 17,663 shares of the medical equipment provider’s stock worth $8,677,000 after purchasing an additional 976 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 48,902 shares of company stock valued at $23,596,360. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.4 %

Shares of NASDAQ ISRG opened at $518.86 on Tuesday. The firm has a 50-day simple moving average of $484.91 and a 200-day simple moving average of $439.55. The stock has a market capitalization of $184.04 billion, a price-to-earnings ratio of 93.66, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $523.34.

Analyst Ratings Changes

Several brokerages have recently issued reports on ISRG. Mizuho boosted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Citigroup upped their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $380.00 to $510.00 in a report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.